Lim James C
SEC CIK 1551804 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BDX | Becton Dickinson | EVP | 23.9K | — | $1.79M | 5 | 2021-09-03 | 2022-06-17 |
Most active insiders at BDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polen Thomas E Jr | COB, CEO, Pres, Dir | — | $1.17M |
| 2 | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | — | $784.2K |
| 3 | Goette Roland | EVP, Pres, EMEA | — | $440.9K |
| 4 | SCOTT BERTRAM L | Dir | — | $212.3K |
| 5 | Feld Michael | EVP, Pres, Life Sciences | — | $167.4K |
| 6 | Menziuso Peter | EVP, Pres, BDI | — | — |
| 7 | Roque Vitor | Interim CFO | — | — |
| 8 | Spikner Pamela L. | SVPController, Chief Acct Off | — | — |
| 9 | Shan David | EVP, Chief ISC Off | — | — |
| 10 | Waldstreicher Joanne | Dir | — | — |
Lim James C made no open-market trades at BDX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-24 | 2022-06-17 | BDX | Becton Dickinson | Lim James C | EVP | A - Grant | $0.00 | +3,280 | 23.9K | +16% | $0 | |
| 2021-11-30 | 2021-11-26 | BDX | Becton Dickinson | Lim James C | EVP | A - Grant | $0.00 | +893 | 20.7K | +5% | $0 | |
| D | 2021-09-07 | 2021-09-03 | BDX | Becton Dickinson | Lim James C | EVP | M - OptEx | $134.73 | +14.6K | 34.4K | +74% | +$1.96M |
| D | 2021-09-07 | 2021-09-03 | BDX | Becton Dickinson | Lim James C | EVP | D - Sale to Iss | $257.44 | -7,628 | 26.7K | -22% | -$1.96M |
| D | 2021-09-07 | 2021-09-03 | BDX | Becton Dickinson | Lim James C | EVP | S - Sale+OE | $257.44 | -6,956 | 19.8K | -26% | -$1.79M |
Purchase Sale Sale after option exercise All abbreviations